Skip to main content
Equibles

UBS Group AG

Position in XGN — Exagen Inc.

CIK 1610520 ZURICH, V8
Back to XGN Full portfolio

Position in XGN

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$18,874
-$64,838 QoQ
Shares Held
4,059
-85.5% QoQ
Ownership
0.017%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#48
of 57 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in XGN Over Time

Shares Held

Position Value (USD)

Position in Diagnostics & Research

Healthcare · as of Jun 30, 2026

UBS Group AG holds $4,492,966,338 across 42 Diagnostics & Research names. XGN ranks #37 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 TMO
Thermo Fisher Scientific Inc.
 2,521,208 $1,264,032,836
2 DHR
Danaher Corp /De/
 3,243,524 $617,826,447
3 WAT
Waters Corp /De/
 694,851 $260,596,916
4 A
Agilent Technologies, Inc.
 1,574,629 $209,157,967
5 RVTY
Revvity, Inc.
 1,864,464 $207,440,262
6 IDXX
Idexx Laboratories Inc /De
 364,663 $191,973,186
7 DGX
Quest Diagnostics Inc
 888,906 $188,403,625
8 MTD
Mettler Toledo International Inc/
 128,025 $163,553,216

All Filings in XGN

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $18,874 4,059
2026-03-31 $83,712 27,904
2025-12-31 $686,972 112,989
2025-09-30 $989,220 90,011
2025-06-30 $3,114,524 446,207
2025-03-31 $224,432 62,516
2024-12-31 $263,289 64,217
2024-09-30 $242,647 78,527
2024-06-30 $113,779 62,516
2024-03-31 $99,400 62,516
2023-12-31 $124,193 62,409
2023-09-30 $316,615 130,833
2023-06-30 $379,415 130,833
2023-03-31 $317,924 130,833
2022-12-31 $328,434 136,848
2022-09-30 $370,762 136,813
2022-06-30 $755,779 131,669
2022-03-31 $1,059,695 131,967
2021-12-31 $1,579,248 135,791
2021-09-30 $1,766,625 129,899
2021-06-30 $1,937,022 129,221
2021-03-31 $2,319,852 132,563
2020-12-31 $11,352 860
2020-09-30 $487 45
2020-06-30 $18,751 1,511
2020-03-31 $30,700 1,926